News
Coave Therapeutics and ABL link up to develop gene therapy manufacturing processes
Coave Therapeutics – a company focused on treating the central nervous system – and ABL, which specialises in the development of viruses for vaccine candidates, gene and cancer therapies, have entered a strategic collaboration to develop its gene therapy manufacturing processes.